×

Sign In

AstraZeneca lifts full-year outlook on upbeat demand for therapies

By Thomson Reuters Jul 25, 2024 | 2:29 AM

(Reuters) – Anglo-Swedish drugmaker AstraZeneca on Thursday raised its sales and profit forecast for 2024 and topped analyst expectations for second-quarter revenue, buoyed by demand for its therapies for cancer and rare diseases.

(Reporting by Pushkala Aripaka in Bengaluru; Editing by Sonia Cheema)

Comments

Leave a Reply Cancel reply

You must be logged in to post a comment.

Warsaw-Modlin airport reopens after bomb threat; second flight checked at Chopin

Musk's pay under a SpaceX-Tesla merger: voting control, but no $1 trillion payday

Retailer Zalando launches AI shopping agent as margins squeezed

Samsung to make AMD, Nvidia chip parts at second Texas plant, Maeil Business reports

NHL roundup: Nazem Kadri, Jaden Schwartz carry Avs past Blackhawks

South Africa braces for some job losses as US trade benefits end